Investor Centre

Shareholder Information

Company overview

Microba Life Sciences (ASX:MAP) is a precision microbiome company driven to improve human health. With world-leading technology for measuring the human gut microbiome, Microba is driving the discovery and development of novel therapeutics for major chronic diseases and delivering gut microbiome testing services globally to researchers, clinicians, and consumers. Through partnerships with leading organisations, Microba is powering the discovery of new relationships between the microbiome, health and disease for the development of new health solutions.

Visit ASX website

 

Shareholder information

Share Price

Please refer to the ASX website for further information.

Listing

Australian Securities Exchange
ASX Code: MAP

Registered Office

Level 10, 324 Queen St
Brisbane, QLD 4000
Telephone: +61 1300 974 621
Fax +61 1300 974 621

 

Directors

Pasquale Rombola – Chairman
Professor Ian Hector Frazer – Deputy Chairman
Dr Caroline Popper – Non-Executive Director
Richard Bund – Non-Executive Director
Professor Gene Tyson – Non-Executive Director
Dr Hyungtae Kim – Non-Executive Director

Senior management

Dr Luke Reid – Chief Executive Officer
James Heath – Chief Financial Officer, Company Secretary
Peter Webse – Joint Co. Secretary

Investor enquiries

Investor Relations

investor@microba.com

Media Relations

Simon Hinsley
Investor / Media Relations
simon@nwrcommunications.com.au